Ovarian Cancer Research Review, Issue 18

In this issue:

Presurgical imaging underestimates peritoneal disease extent
Achieving complete gross resection more important than timing of interval surgery in high-grade OC
Factors associated with response to NACT in advanced stage OC
Impact of the time interval between primary debulking surgery and adjuvant chemotherapy
Ovarian cancer population screening does not save lives
PHAEDRA: durvalumab has clinical activity in dMMR advanced endometrial cancer
JAVELIN Ovarian 200 finds no survival benefit to avelumab for platinum resistant/refractory OC
No benefit to atezolizumab for newly diagnosed stage 3 or 4 OC in IMagyn050
Should adjuvant therapy be omitted in patients with POLE-mutated endometrial cancer?
Maintenance PARP inhibition confers a PFS benefit in platinum-sensitive, recurrent OC

Please login below to download this issue (PDF)

Subscribe